#sgyp

[abrcapfinancial-blog]

EARNING UPDATE $SGYP Synergy Pharmaceuticals Inc. for quarter ending q_Jun18 - Revenue grew, Margins expanded

EARNING UPDATE $SGYP Synergy Pharmaceuticals Inc. for quarter ending q_Jun18 – Revenue grew, Margins expanded

[s2If !current_user_can(access_s2member_level0)]Please login to read the earning update on SGYP [lwa][/s2If][s2If current_user_can(access_s2member_level0)]Synergy Pharmaceuticals Inc. reported earnings (EPS) of -0.12 per share for the quarter ending q_Jun18. This is vis-vis -0.15 per share for the previous quarter ending q_Mar18, a growth of 20 %. Compared to last year same quarter (q_Jun17),…

View On WordPress

[pitypangharcos]

“Mindenesetre nagyon bízunk Orbán Viktorban...”

[alphabetastock-blog]

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has grabbed attention from the analysts, when it experienced a change of 12.07% in the last trading session to close at $3.25. A total of 13,155,432 share…

[alphabetastock-blog]

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has grabbed attention from the analysts, when it experienced a change of 8.62% in Monday’s afternoon trading session to trade at $3.15. A total of 9,209,5…

[marketexclusive]

Analyst Activity – Canaccord Genuity Reiterates Buy on Synergy Pharmaceuticals (NASDAQ:SGYP)

Analyst Activity – Canaccord Genuity Reiterates Buy on Synergy Pharmaceuticals (NASDAQ:SGYP)

Analyst Ratings For Synergy Pharmaceuticals (NASDAQ:SGYP) Today, Canaccord Genuity reiterated its Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with a price target of $13.00. There are 1 hold rating, 5 buy ratings on the stock. The current consensus rating on Synergy Pharmaceuticals (NASDAQ:SGYP) is Buy (Score: 2.83) with a consensus target price of $11.25 per share, a potential 94.97%…

View On WordPress

[marketexclusive]

Analyst Activity – Canaccord Genuity Reiterates Buy on Synergy Pharmaceuticals (NASDAQ:SGYP)

Analyst Activity – Canaccord Genuity Reiterates Buy on Synergy Pharmaceuticals (NASDAQ:SGYP)

Analyst Ratings For Synergy Pharmaceuticals (NASDAQ:SGYP) Today, Canaccord Genuity reiterated its Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with a price target of $13.00. There are 1 hold rating, 5 buy ratings on the stock. The current consensus rating on Synergy Pharmaceuticals (NASDAQ:SGYP) is Buy (Score: 2.83) with a consensus target price of $11.25 per share, a potential 94.97%…

View On WordPress

[marketexclusive]

Stillwater Mining Company (NYSE:SWC) Files An 8-K Entry into a Material Definitive Agreement

Stillwater Mining Company (NYSE:SWC) Files An 8-K Entry into a Material Definitive Agreement

Stillwater Mining Company (NYSE:SWC) Files An 8-K Entry into a Material Definitive Agreement ITEM1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On December 9, 2016, Stillwater Mining Company (Stillwater) entered into an Agreement and Plan of Merger (the Merger Agreement) with Sibanye Gold Limited (Parent or Sibanye), Thor US Holdco Inc. (US Holdco) and Thor Mergco Inc., an indirect wholly owned…

View On WordPress

[marketexclusive]

Philip Morris International Inc. (NYSE:PM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Philip Morris International Inc. (NYSE:PM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Philip Morris International Inc. (NYSE:PM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. On December 6, 2016, the Board of Directors of Philip Morris International Inc. (the…

View On WordPress